NEW YORK LIFE INVESTMENTS ET - CANDRIAM US LRG (IQSU)

Historical Holders from Q4 2019 to Q3 2025

Type / Class
Equity / CANDRIAM US LRG
Symbol
IQSU
Price per share
$53.19
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
4,827,312
Total reported value
$256,777,549
% of total 13F portfolios
0%
Share change
-2,009,813
Value change
-$100,305,659
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, NEW YORK LIFE INVESTMENTS ET - CANDRIAM US LRG (IQSU) has 23 institutional shareholders filing 13F forms. They hold 4,827,312 shares. .

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - CANDRIAM US LRG (IQSU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 4,827,312 $256,777,549 -$100,305,659 5,319.3% 23
2025 Q2 6,837,099 $339,053,500 -$29,649,222 4,959.03% 24
2025 Q1 7,437,683 $337,343,365 -$716,737 4,535.6% 25
2024 Q4 7,504,712 $363,303,153 -$2,579,899 4,841% 25
2024 Q3 7,545,233 $361,186,264 -$21,206,677 4,786.94% 27
2024 Q2 7,996,012 $363,618,274 -$24,226,024 4,547.48% 24
2024 Q1 8,528,746 $378,312,809 -$12,633,645 4,436% 22
2023 Q4 8,823,159 $370,475,188 +$17,170,653 4,199% 23
2023 Q3 8,402,980 $314,264,233 -$51,544,055 3,738.25% 19
2023 Q2 9,776,588 $379,252,642 -$41,457,594 3,879.08% 19
2023 Q1 10,817,009 $380,844,172 -$9,048,163 3,527.94% 17
2022 Q4 11,066,994 $353,955,940 -$2,012,134 3,198.3% 13
2022 Q3 11,134,533 $341,664,000 -$16,623,777 3,068.44% 16
2022 Q2 11,673,916 $377,073,000 -$12,650,610 3,229.79% 14
2022 Q1 12,065,540 $471,523,000 -$4,034,538 3,908.35% 11
2021 Q4 12,170,740 $506,684,000 -$16,735,513 4,163.13% 14
2021 Q3 12,578,764 $467,435,000 +$21,028,212 3,716.07% 11
2021 Q2 12,012,830 $442,039,000 +$25,031,307 3,679.57% 10
2021 Q1 11,336,776 $383,322,000 +$40,443,633 3,380.69% 8
2020 Q4 10,140,973 $327,364,000 +$153,092,059 3,228.1% 6
2020 Q3 5,366,446 $155,933,000 +$93,983,406 2,905.73% 4
2020 Q2 2,131,987 $55,953,000 +$49,827,304 2,624.48% 4
2020 Q1 233,418 $4,973,000 -$172,088 2,130.44% 2
2019 Q4 241,496 $6,155,000 +$6,154,998 2,548.35% 2